Insights

Growth Through Acquisition EUSA Pharma was acquired by Recordati Rare Diseases in 2022 for approximately $824M, highlighting its emerging presence within a larger pharmaceutical group. This expansion creates opportunities for cross-group collaborations, co-marketing, and integration into broader sales channels.

Strong Focus on Rare Diseases As part of Recordati's dedicated rare disease division, EUSA Pharma specializes in oncology and rare disease treatments, making it a strategic partner for specialized therapies, niche markets, and targeted sales initiatives focused on unmet medical needs.

Market Position and Revenue With estimated revenues between $25M and $50M and approximately 201-500 employees, EUSA Pharma presents a mid-sized opportunity for pharmaceutical suppliers, service providers, and distributors aiming to penetrate the rare disease and oncology segments.

Strategic Leadership Changes Recent executive appointments and leadership transitions, including new CEOs and CFOs, suggest a dynamic company focused on strategic growth and innovation, indicating potential for onboarding innovative solutions, consulting, and partnership opportunities.

Technological and Digital Engagement EUSA Pharma employs advanced tech platforms including AWS, WordPress, and Google Analytics, which opens avenues for digital service providers, analytics tools, and tech-enabled marketing solutions to support their growth and operational efficiency.

Similar companies to EUSA Pharma

EUSA Pharma Tech Stack

EUSA Pharma uses 8 technology products and services including Trident AB, Amazon Web Services, WordPress, and more. Explore EUSA Pharma's tech stack below.

  • Trident AB
    A/B Testing
  • Amazon Web Services
    Cloud Hosting
  • WordPress
    Content Management System
  • Zendesk
    Documentation Tools
  • DreamWeaver
    Editors
  • JSON-LD
    Javascript Frameworks
  • Google Analytics
    Web Analytics
  • Dynamic Conditions
    Widgets

Media & News

EUSA Pharma's Email Address Formats

EUSA Pharma uses at least 1 format(s):
EUSA Pharma Email FormatsExamplePercentage
First.Last@eusapharma.comJohn.Doe@eusapharma.com
52%
FLast@eusapharma.comJDoe@eusapharma.com
46%
First.Middle@eusapharma.comJohn.Michael@eusapharma.com
1%
First_Last@eusapharma.comJohn_Doe@eusapharma.com
1%

Frequently Asked Questions

What is EUSA Pharma's phone number?

Minus sign iconPlus sign icon
You can contact EUSA Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is EUSA Pharma's official website and social media links?

Minus sign iconPlus sign icon
EUSA Pharma's official website is eusapharma.com and has social profiles on LinkedInCrunchbase.

What is EUSA Pharma's NAICS code?

Minus sign iconPlus sign icon
EUSA Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does EUSA Pharma have currently?

Minus sign iconPlus sign icon
As of December 2025, EUSA Pharma has approximately 201 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Vice President - Publications: J. T.Head Of Hr Us, Europe And Emerging Markets: E. H.Owner And Senior Consultant: L. C.. Explore EUSA Pharma's employee directory with LeadIQ.

What industry does EUSA Pharma belong to?

Minus sign iconPlus sign icon
EUSA Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does EUSA Pharma use?

Minus sign iconPlus sign icon
EUSA Pharma's tech stack includes Trident ABAmazon Web ServicesWordPressZendeskDreamWeaverJSON-LDGoogle AnalyticsDynamic Conditions.

What is EUSA Pharma's email format?

Minus sign iconPlus sign icon
EUSA Pharma's email format typically follows the pattern of First.Last@eusapharma.com. Find more EUSA Pharma email formats with LeadIQ.

EUSA Pharma

Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees

We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care.

Helping the people with few or no options available is at the heart of everything we do. 

EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. 

Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf

We see a need. We work together. We don’t give up.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $25M$50M

    EUSA Pharma's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    EUSA Pharma's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.